Menu
Recruiting NCT07082998

Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression

No phase Interventional Depression Disorders Depression - Major Depressive Disorder Depression Disorder Depression Chronic

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: heated yoga, sauna, mindfulness app.
Who it may be relevant to
Registry conditions: Depression Disorders, Depression - Major Depressive Disorder, Depression Disorder, Depression Chronic. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This project explores whether heated yoga, sauna, and a mindfulness app reduce depressive symptoms

Detailed description

This is a parallel group study design. The investigators plan to enroll 120 adults who have at least moderate depression and will be randomized in an equal allocation ratio (i.e., 1:1:1) across three groups: heated yoga vs. sauna vs. a mindfulness app. The interventions will be provided over a 12-week period and assessments will occur at baseline (Week 0), mid-intervention (Weeks 4 \& 8), post-intervention (Week 12, primary outcome), and at a 4-week (Week 16). Then participants enter an optional 1-month choice intervention period with a post-assessment (Week 20).

Interventions

  • Behavioral heated yoga
    12-weeks of twice weekly 90-min heated yoga classes in the community
  • Behavioral sauna
    12-weeks of twice weekly 40-min sauna sessions in the community
  • Behavioral mindfulness app
    12-weeks of 80-mins a week of a mindfulness app

Primary outcome measures

  • Patient Health Questionnaire (PHQ-9) [Time frame: Weeks 0, 4, 8, 12, 26, 20]
Secondary outcome measures (4)
  • The Five Facet Mindfulness Questionnaire (FFMQ-15) [Time frame: Weeks 0, 4, 8, 12, 16, 20]
  • Ruminative Responses Scale (RRS) [Time frame: Weeks 0, 4, 8, 12, 16, 20]
  • The World Health Organization-5 Well-Being Index (WHO-5) [Time frame: Weeks 0, 4, 8, 12, 16, 20]
  • Patient-Reported Outcomes Measurement Information System (PROMIS-29) [Time frame: Weeks 0, 4, 8, 12, 16, 20]

Eligibility criteria

Subject Characteristics

Inclusion criteria

  • adults (18-65 years old)
  • Ability to provide informed consent
  • English language proficiency
  • PHQ-9 score > 10, indicating at least moderate depressive symptoms 21
  • Must have filled out the waiver for the community-based partners prior to enrolling in the study\*
  • Individuals of childbearing potential must use an acceptable form of birth control
  • (if applicable) willingness to keep psychiatric medications and psychotherapy stable throughout the course of the study
  • Must be able to access mindfulness app on a device (i.e., smartphone, iPad, etc.)
  • Can travel to Breathe in Harvard Square and at least one Restore location (i.e., Hingham, Somerville, Dedham, Newton, Lynnfield)

Exclusion criteria

  • Pregnant or planning to become pregnant
  • Breast feeding
  • Active suicidal thinking (i.e., PHQ-9 item 9 ≥1 and a positive response to C-SSRS screener items 3, 4, 5, or 6)
  • Active eating disorders or substance use disorders within the past 12 months, as per the MINI
  • Primary OCD or PTSD, as per the MINI
  • History of bipolar disorder, psychotic disorders, as per the MINI
  • ≥25% drop in PHQ-9 score from screen to baseline
  • Under the influence or withdrawal of drugs or alcohol
  • Positive urine toxicology screen due to illicit drug use or other exclusionary medications. (Potential false positives will be addressed on a case-by-case basis at the discretion of the PI or designee)
  • have had a bone fracture or joint surgery in the past 6 months
  • not able to walk freely or without difficulty
  • any serious, unstable medical condition as determined by the revised Physical Activity Readiness Questionnaire (PAR-Q+) and do not have approval from their treating physician (we will check in with treating physician in the event that participants endorse any item on the PAR-Q+)
  • participants must have a healthcare provider who they could contact if they needed medical care, such as a primary care doctor, a counselor, a psychiatrist, a nurse practitioner, or a clinic that you go to.
  • Significant exposure to heated yoga classes in the past 3 months (i.e., more than 6 classes)
  • Significant exposure to sauna sessions in the past 3 months (i.e., more than 6 sessions)
  • Significant exposure to mindfulness app in the past 3 months (i.e., more than 6 uses of the app)
  • are on medications that make dehydration more likely (e.g., lithium, antipsychotics, insulin-dependent) diuretics, barbiturates, b-blockers, anticholinergics, current ETOH acute intoxication, reduced ability to sweat, hemophilia, pacemaker (magnets used to assemble saunas can interrupt the pacer)
  • antidepressant or psychiatric medications that are initiated less than 8 weeks or a dose change less than 4 weeks prior to screening visit
  • psychotherapy that has been initiated within the past 3 months
  • psychiatric hospitalization within the past year
  • diagnosed with any neurological disorders that would impact participation or make participation unsafe
  • are currently in active ketamine, Electroconvulsive therapy, or Transcranial Magnetic Stimulation treatments
  • are unable to follow the study procedures (e.g., not able to travel to the heated yoga or sauna studios)
  • A subject who in the opinion of the Principal Investigator would not be able to safely complete the study or would jeopardize study integrity

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Massachusetts General Hospital — Boston

Identifiers

NCT: NCT07082998 · 2025P001188

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗